Please login to the form below

Not currently logged in
Email:
Password:

Novocure

This page shows the latest Novocure news and features for those working in and with pharma, biotech and healthcare.

Novocure recruits trio of ex-OSI Pharmaceuticals executives

Novocure recruits trio of ex-OSI Pharmaceuticals executives. Peter Melnyk, Angela Davies and Laura Benson join company's global commercialisation team. ... Novocure has added three senior oncology executives to its global management team to support its

Latest news

  • FDA advisors back oncology device

    FDA advisors back oncology device. Advisors to the US FDA have voted in favour of Novocure's noninvasive medical device designed to slow tumour growth. ... Novocure is currently conducting a phase III study comparing use of the device plus Merck's

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    Novocure’ s chief commercial officer to step down. Peter Melnyk will leave the oncology specialist on 15 March. ... Peter Melnyk, Novocure's chief commercial officer is set to step down from 15 March this year.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics